contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
      id
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    pageUrl
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


h100-group-enters-into-a-tech-partnership-with-epivity-health

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

H100 Group is a health technology company operating in the health and longevity industry. The company's business concept is to support providers of health and lifestyle services through AI-driven automation, digital growth tools and integrated platform solutions. The company follows a growth strategy focused on building an ecosystem where AI integration increases efficiency and expands the service offering. H100 Group is headquartered in Stockholm.

H100 Group

H100 Technology AS (“H100 Technology”), indirectly a wholly owned subsidiary of H100 Group AB (“H100 Group” or the “Company”), has entered into a technology supplier agreement with Epivity Health...

<div class="mfn-preamble"><p><strong>H100 Technology AS (“H100 Technology”), indirectly a wholly owned subsidiary of H100 Group AB (“H100 Group” or the “Company”), has entered into a technology supplier agreement with Epivity Health AS (“Epivity”), Norway’s first longevity clinic.</strong></p></div><div class="mfn-body"><p>Under the agreement, H100 Technology will deliver and customize its digital health platform to support Epivity’s patient engagement and care tracking systems, tailored to fit Epivity’s brand and clinical workflows.</p><p>“<em>This is an important first milestone in our mission to build a comprehensive digital health ecosystem</em>&nbsp;<em>and this agreement marks the expansion for H100 Group as it moves beyond its roots in exercise and nutrition coaching to serve the fast-growing longevity sector.</em>” said Sander Andersen, CEO of H100 Group. And he further comments; “<em>By partnering with Epivity, we’re continuing our strategy of supporting industry-leading health providers with digital tools by bringing our scalable technology to the forefront of the longevity movement. And I believe it demonstrates how our platform can power personalized, preventative care across emerging sectors.</em>”</p><p>Epivity, the first clinic of its kind in Norway, focuses on health optimization, age reversal, nutrition, and performance, using cutting-edge science and expert guidance to help people live longer, healthier lives. For further information about Epivity see&nbsp;<a rel="noopener" href="https://www.epivity.no/">https://www.epivity.no/</a>.</p></div><div class="mfn-footer mfn-contacts mfn-49381eadf453"><p><strong class="mfn-heading-1">Contact</strong></p><hr><p>Sander Andersen, CEO H100 Group AB<br>E-mail: <a rel="noopener" href="mailto:sander.andersen@h100.group">sander.andersen@h100.group</a></p></div><div class="mfn-footer mfn-about mfn-057509ecf22f"><p><strong class="mfn-heading-1">About H100 Group</strong></p><hr><p>H100 Group AB is a health technology company operating in the health and longevity industry. The company’s business idea is to support providers of health and lifestyle services through AI-powered automation, digital growth tools, and integrated platform solutions, with the goal of helping people live healthy lives to 100 and beyond.<br>H100 follows a clear growth strategy focused on building a seamless ecosystem where AI integration enhances efficiency and expands service offerings. Growth is further accelerated through strategic acquisitions of key players within its ecosystem, aiming to consolidate and scale the business.<br>The company is listed on NGM Nordic SME. For more information, visit <a rel="noopener" href="http://www.h100.group">www.h100.group</a>.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/c8ad806e-78db-4471-b2ae-da7db5558288/h100-group-enters-into-a-tech-partnership-with-epivity-health.pdf" class="mfn-generated mfn-primary">H100 Group enters into a tech partnership with Epivity Health</a></p></div>